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1. Introduction
  In some western countries and large cities of China, lung 
cancer has the highest morbidity of all malignancies in men. 
It accounted for 1.2 million new cases and 1 million deaths 
every year[1]. Non-small cell lung cancer (NSCLC) accounts 
for about 80% of all lung cancers, and is always diagnosed at 
an advanced stage. Despite advances in surgical therapies, 
radiotherapies and chemotherapies, the prognosis of NSCLC 
patients is still poor, with a 5-year overall survival rate at 
less than 20%[2]. Therefore, clinicians and scientists need to 
find novel strategies for more effective treatments. Recent 
research has determined that the change of multiple key 
molecules or signal pathways can promote the occurrence 
and the development of lung cancer via affect lung cancer 
cell proliferation, migration and invasion.
  Annexin栻protein has multiple functions in the cytoplasm 
and nucleus, its abnormal expression is correlated to 
tumorigenesis and development. The purpose of this article 
was to explore the relationship between Annexin栻and lung 
cancer.
2. Materials and methods
2.1. Materials
  Bronchial epithelial cells BEAS-2B, human lung 
adenocarcinoma A549, human lung squamous cell 
carcinoma line EBC-1 and control group cells were obtained 
from Cell Resource Center of Institute of Biochemistry and 
Cell Biology, Chinese Academy of Sciences (Shanghai, 
China). RPMI 1640 medium and trypsinogen were purchased 
from Gibco GRL (Grand Island, NY, USA).Trizol was 
purchased from Invitrogen (Carlsbad, California, USA).
2.2. Clinical sample preparation
  Tumor specimens (n=75) were obtained from patients 
[male n=42, female n=53, mean age:  (61.0暲7.1) years old] 
with lung cancer who underwent surgical resection and 
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diagnosed by pathology in XX hospital. The carcinomas and 
their pericarcinous tissues (1.0 cm暳0.5 cm暳0.5 cm) were 
immediately frozen in liquid nitrogen and stored at -80 曟
refrigerator. 
2.3. Cell culture
  Different differentiated human lung cancer cell lines 
(human lung adenocarcinoma A549, human lung squamous 
cell carcinoma line EBC-1) and bronchial epithelial cells 
BEAS-2B were maintained under a humidified atmosphere 
of 5% CO2 at 37 曟 in RPMI 1640 medium (Invitrogen), 
supplemented with 10% fetal bovine serum, 100 U/mL 
penicillin and 100 mg/mL streptomycin. Cells were digested 
by 0.25% trypsin which contains 0.02% EDTA.
2.4. Reverse transcription and PCR analysis
 
  Total RNA from tissue or cells was isolated with Trizol, 
and 2 毺L RNA was used for cDNA synthesis. Using 毬
-actin as internal standard control, 2 毺L cDNA was used as 
a template for PCR amplification to detect the target gene 
mRNA expression levels. According the kites instruction, 
20 毺L PCR system was established: 2 毺L cDNA, 10 毺L
SYBR Green Mix (Applied Biosystems, Foster City, CA), 
0.5 毺L upstream primer and downstream primer 
(10 毺mol/L). PCR amplification was performed with 5 min at 
95 曟, 45 cycles of 30 sec at 94 曟, 30 sec at 60 曟. Before the 
experiment, primers were designed by Primer 5.0, and tested 
for specificity by Blast. The primer is as follows: Annexin
栻primers: 5’-CAAATTCACCGAGATCCTGT-3’ and 5’-
TGCTGGAGTGCTGTACGAAA-3’, 毬-actin: upstream primer 
5’-ACCACAGTCCATGCCATCAC-3’, downstream primer 5’-
TCCACCACCCTGTTGCTGTA-3’. Electrophoresis images 
were analyzed by GelprO4 gel documentation analysis 
software. The numbers were mean optical density, which 
stand for the expression level of the gene.
2.5. West-blot
  Equal amounts (60 毺g) of protein were separated on 12% 
SDS-polyacrylamide gels and transferred to polyvinylidene 
fluoride membranes. After blocking in 5% non-fat milk in 
TBST buffer for 1 hour at room temperature, the membranes 
were incubated overnight at 4℃ with primary anti- bodies 
to target protein or 毬-actin, then washed with TPBS 3 
times and incubated in horseradish peroxidase-conjugated 
secondary antibodies for 1 h at room temperature. The 
bands were detected by method of scan the absorbance after 
chemiluminescence. 
2.6. Stastical analysis
  All data are presented as mean暲SD. The difference 
between means was analyzed using t-test or one-way 
ANOVA. All statistical analyses were performed using SPSS 
11.5 software. P values <0.05 were considered statistically 
significant.
3. Results
3.1. Expression of Annexin 栻 in lung cancer and their 
pericarcinous tissues
  In order to clarify the function of Annexin栻in the 
development of lung cancer, we investigate the expression 
of Annexin栻in lung cancer and their pericarcinous tissues 
by RT-PCR, Western blot and immunohistochemistry. 
The results showed that, compared with pericarcinous 
tissues, the expression of Annexin栻mRNA in lung cancer 
was significantly increased (P<0.05) (Figure 1, Table 1). 
Western blotting revealed that Annexin栻proteins increased 
dramatically in lung cancer, compared with pericarcinous 
tissues (P<0.05) (Figure 2, Table 1).  
Table 1
Expression of Annexin 栻in different tissues.
Number RT-PCR Western blot
1 0.38 1.42
2 0.37 1.32
3 0.42 1.59
4 0.41 1.49
5 0.36 1.65
6 0.96* 2.21*
7 1.06* 2.23*
8 0.80* 2.89*
9 0.91* 2.81*
10 0.85* 2.78*
Compared with pericarcinous tissues: *P<0.05.
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Figure 1. Expression of Annexin栻mRNA in different tissues.
1-5: pericarcinous tissues; 6-10: lung cancer.
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Figure 2. Expression of Annexin栻proteins in different tissues.
3.2. Expression of Annexin 栻 in lung cell lines
  In order to reveal the relationship between Annexin 栻
and the development of lung cancer, We further observed 
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Annexin栻gene expression and correlation of lung cancer. 
The result of PCR and western blot showed that the 
expression of Annexin栻mRNA or Annexin栻protein varied 
from normal cells to lung cancer cells. Compared with 
normal bronchial epithelial cells, the expression of Annexin
栻in adenocarcinoma and squamous cancer cells were 
significant increase (P<0.05) (Table 2, Figure 3, Figure 4). 
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Figure 3. Expression of Annexin栻mRNA between different cell 
lines. 
1: BEAS-2B, 2: A549, 3: EBC-1.
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Figure 4. Expression of Annexin栻protein between different cell lines. 
1: BEAS-2B, 2: A549, 3: EBC-1.
Table 2 
Expression of Annexin栻mRNA or protein between different cell lines.
Cell line RT-PCR Western blot
control 0.772 0.32
EBC-1 1.612* 0.74*
A549 2.402* 1.23*
Compared with control group, *P<0.05.
4. Discussion
  The incidence of Lung cancer continues to increase in the 
world and larger cities of China. The abnormal expression of 
the genies is one of the mechanisms of tumorigenesis.
  Annexin family are Ca2+ phospholipid proteins, which 
exist in cytoplasmic. They are expressed at high level, 
accounting for 1%-2% of the total protein. Annexin exists 
in two forms: soluble form and combining form-combining 
with cytoskeletal protein or extracellular matrix proteins[3].
The gene and protein molecular structure of Annexin栻is 
roughly same with membrane group protein family, which 
is a long repeats composed of 70 amino acids. A number 
of long repeats compose a homologous region, and every 
homologous region form five alpha helix. These areas are 
located in a plane, compose two symmetrical disk structures. 
In spite of the different N-terminal, Annexin family proteins 
are all binds to phospholipids and membranes in a Ca2+-
dependent manner[4]. Research shows that several diseases 
associate with the abnormal expression of Annexin family 
proteins. The members of Annexin family are related to 
tumor proliferation, differentiation, invasion, migration, and 
clinical stages. Annexin family proteins are getting more and 
more importance in the tumor development, and become the 
focus fields of cancer research recently[5,6].
  A great deal of research show that the change of the 
expression of effects tumor development, drug resistance, 
and metastasis. The expression lever of Annexin栻vary from 
tumor type, and play an important role in DNA synthetizing. 
Zhang et al found that Annexin栻and S100A10 are over 
expressed in human breast cancer cell. Hyperproteolysis of 
Annexin栻or escape the degradation by proteasome might 
be a reason which leads to breast cancer[7]. Research shows 
that Annexin A5 is related to the differentiation of uterine 
squamous cell carcinoma. Hellman et al[8] considered that 
Annexin栻are also aberrantly expressed in cervical cancer.
  Above all, we find that the expression lever of Annexin
栻is related to the proliferation and differentiation of Lung 
cancer. Our results confirm the significantly high expression 
of Annexin栻in lung cancer tissue and cells. Based on 
these findings, We can assume that Annexin栻might be a 
negative marker to tumor progression. Although the exact 
mechanism is not very clear and needs more investigations, 
these results have already suggested that Annexin栻play 
an important role in the lung cancer development as an 
oncogene. And further research is needed to study whether 
Annexin栻-siRNAs could silent the genes and inhibit the 
differentiation and proliferation of tumor cells.
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